NASDAQ:ALBO
Delisted

Albireo Pharma Stock Signals

etoro logo Buy ALBO
*Your capital is at risk
$44.15
+0 (+0%)
At Close: May 26, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Albireo Pharma Inc

General

Signal Type Signal Value Data
Score 0.000 103 days ( -103.83 %
Last Price $44.15 0 %
Performance History
7 Days
$44.15 $44.15
0%
30 Days
$44.15 $44.15
0%
12 Mos
$20.05 $44.15
120.20%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $44.15 - $44.15
Trend - 3 mos -0.150 % High Width: 0.90 %
Pred. range - 3 mos $44.02 - $44.42 Low -0.289 % - 0.611 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Mar 02, 2023 - 61 days
RSI Short Pivot Signal Buy Very Low Mar 17, 2023 - 50 days
Short MA 3 mos Sell Low Mar 03, 2023 - 60 days
Long MA 3 mos Sell Medium Apr 13, 2023 - 32 days
Short/Long MA 3 mos Sell Medium Apr 13, 2023 - 32 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.75
Signal Type Signal Value Importance Data
Trend - 12 mos 129.57 % Very High Width: 84.69 %
Pred. range - 12 mos $73.00 - $134.82 High 65.35 % - 205.37 %
Short MA 12 mos Sell Very High Mar 10, 2023 - 55 days
Long MA 12 mos Buy Very High Dec 28, 2022 - 104 days
Short/Long MA 12 mos Buy Very High Jan 04, 2023 - 100 days
Pivot Long Sell Low Feb 03, 2023 - 79 days
RSI Long Pivot Signal Buy Low Mar 28, 2023 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ALBIREO PHARMA INC
Albireo Pharma
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-th...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE